Suksawat Thongtham, Panichayupakaranant Pharkphoom
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai 90112, Thailand.
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai 90112, Thailand; Phytomedicine and Pharmaceutical Biotechnology Excellence Center, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai 90112, Thailand.
J Pharm Biomed Anal. 2023 Feb 5;224:115177. doi: 10.1016/j.jpba.2022.115177. Epub 2022 Nov 22.
Rhinacanthus nasutus has been traditionally used for skin infections, diabetes, inflammatory disorders and cancer therapies. Rhinacanthin-C, -D, and -N have been identified as its bioactive compounds. The content of active compounds in herbal raw materials and health products usually varies due to various factors, such as plant genetics, climate, and harvesting process. The present study aimed to determine the effect of harvesting factors, including part use and harvesting periods on rhinacanthin content of raw materials and health products of R. nasutus. Six parts of R. nasutus raw materials, i.e., leaves, flowers, roots, green twigs, brown twigs and aerial parts that separately harvested every two months together with two commercially available products of R. nasutus tea were extracted using a microwave-assisted extraction and subjected to quantitative HPLC analysis of rhinacanthin-C, -D, and -N. Among the plant parts, the roots contained the highest content of total rhinacanthins, followed by the leaves, in all every harvesting periods. While the other parts contained very low content of total rhinacanthins. In addition, the highest content of total rhinacanthins accumulated in roots (4.91 %, w/w) and leaves (4.42 %, w/w) were observed when they were harvested in September, while the lowest ones (3.73 % and 3.18 %, w/w, respectively) were found in March. In contrast, R. nasutus powders obtained from ten suppliers and two tea products contained very low content of total rhinacanthins and varied in the ranges of 0.14-0.55 %, w/w, which similar to those observed in the aerial part powders (0.27-0.53 %, w/w).
长穗木传统上用于治疗皮肤感染、糖尿病、炎症性疾病和癌症。已鉴定出长穗木素-C、-D和-N为其生物活性化合物。由于植物遗传学、气候和收获过程等各种因素,草药原料和保健品中活性化合物的含量通常会有所不同。本研究旨在确定收获因素,包括部位使用和收获期对长穗木原料和保健品中长穗木素含量的影响。长穗木原料的六个部位,即叶、花、根、绿枝、褐枝和地上部分,每两个月分别收获一次,连同两种市售的长穗木茶产品,采用微波辅助萃取法进行萃取,并对长穗木素-C、-D和-N进行高效液相色谱定量分析。在所有收获期,在植物各部位中,根中总长穗木素含量最高,其次是叶,而其他部位总长穗木素含量极低。此外,9月收获时,根(4.91%,w/w)和叶(4.42%,w/w)中总长穗木素积累量最高,而3月收获时含量最低(分别为3.73%和3.18%,w/w)。相比之下,从10个供应商处获得的长穗木粉末和两种茶产品中总长穗木素含量极低,在0.14-0.55%(w/w)范围内变化,与地上部分粉末(0.27-0.53%,w/w)中观察到的含量相似。